Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2015
Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventionsR W F van Leeuwen, F G A Jansman, P M L A van den Bemt, et al.
ESMO Open|December 9, 2022
Sex differences in patients with gastrointestinal stromal tumours: do they exist and does it affect survival?N S IJzerman, E van Werkhoven, M Mohammadi, et al.
The Pharmacogenomics Journal|September 9, 2015
Role of genetic variation in docetaxel-induced neutropenia and pharmacokineticsA J M Nieuweboer, M Smid, A-J M de Graan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 24, 2014
Induction chemotherapy followed by surgery for advanced oesophageal cancerE L A Toxopeus, S Talman, A van der Gaast, et al.
Clinical Pharmacology and Therapeutics|September 6, 2012
Polymorphisms in endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) predict sunitinib-induced hypertensionK Eechoute, A A M van der Veldt, S Oosting, et al.
Oncogene|October 10, 2012
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cellsM T M van Jaarsveld, J Helleman, A W M Boersma, et al.
Clinical Pharmacology and Therapeutics|February 26, 2014
Association analysis of genetic polymorphisms in genes related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662M H M Diekstra, H J Klümpen, M P J K Lolkema, et al.
ESMO Open|February 15, 2025
Palbociclib exposure in relation to efficacy and toxicity in patients with advanced breast cancerS M Buijs, M I Mohmaed Ali, E Oomen-de Hoop, et al.
British Journal of Cancer|April 15, 2004
Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitorA Sparreboom, D F S Kehrer, R H J Mathijssen, et al.
British Journal of Cancer|August 24, 2013
MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumoursC M M Gits, P F van Kuijk, M B E Jonkers, et al.
Pageof 5